OakChart

Joint Corp

JYNTHealthcare·Medical Care Facilities·USA·Micro·NASD·Nov 11 • 3:59 PM ET

6.80-0.03 (-0.44%)
2026-11-11 23:53 CET
Market cap
93.50 USD m
Revenue, TTM
58.72 USD m
Net income, TTM
2.83 USD m
Free cash flow, TTM
2.26 USD m
EPS diluted, TTM
0.20
P/E
34.52
Compare

Price

JYNT against its 20, 50 and 200-day averages
2050200miss
7.008.009.00741K1.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26JYNTclose 6.8020-day 7.1450-day 7.57200-day 8.476.8052w low

36.3% under the 52-week high of 10.67 on 16 Jan 2026. 52-week low 6.52 on 9 Nov 2026. Last 15 sessions, 17.0% high to low

Volume 0.60× normal · the line is the 50-bar volume average

Profile

JYNT
52-week range, 7% of the way up
6.5210.67

The Joint Corp. engages in the revolutionizing access to chiropractic care by making quality healthcare affordable for patients seeking pain relief and ongoing wellness. It operates through the Corporate Clinics and Franchise Operations segments. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Employees330
IPONov 11, 2014
Beta1.15
ATR, 14d0.30
Rel volume0.60
Short float2.82%
Insider own16.23%
Inst own70.20%

Snapshot

6 groups

Valuation

Index-
Market Cap93.09M
Enterprise Value76.20M
Income2.83M
Sales58.72M
Book/sh0.89
Cash/sh1.38
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees330
IPONov 11, 2014

Ratios

P/E34.52
Forward P/E21.15
PEG1.03
P/S1.59
P/B7.61
P/C4.93
P/FCF41.19
EV/EBITDA12.17
EV/Sales1.30
Quick Ratio1.91
Current Ratio1.91
Debt/Eq0.16
LT Debt/Eq0.13
Option/ShortYes / Yes

Earnings

EPS (ttm)0.20
EPS next Y0.32
EPS next Q0.09
EPS this Y1317.34%
EPS next Y32.08%
EPS next 5Y20.63%
EPS past 3/5Y64.32% -26.62%
Sales past 3/5Y-18.46% -1.33%
EPS Y/Y TTM55.56%
Sales Y/Y TTM7.86%
EPS Q/Q-115.14%
Sales Q/Q1.28%
EarningsNov 05 AMC
EPS/Sales Surpr.25.00% -8.73%

Ownership

Insider Own16.23%
Insider Trans6.11%
Inst Own70.20%
Inst Trans-6.45%
ROA5.90%
ROE18.57%
ROIC20.41%
Gross Margin79.64%
Oper. Margin8.05%
Profit Margin4.81%
SMA20-4.78%
SMA50-10.12%
SMA200-19.74%
Trades-

Technical

Shs Outstand13.70M
Shs Float11.47M
Short Float2.82%
Short Ratio4.07
Short Interest0.32M
52W High10.67 -36.27%
52W Low6.52 4.29%
Volatility5.14% 3.91%
ATR (14)0.30
RSI (14)40.08
Beta1.15
Rel Volume0.60
Avg Volume79.40K
Volume47,924

Performance

Perf Week-9.45%
Perf Month-2.51%
Perf Quarter-19.24%
Perf Half Y-18.07%
Perf YTD-22.02%
Perf Year-16.56%
Perf 3Y-18.27%
Perf 5Y-92.88%
Perf 10Y167.72%
Recom2.50
Target Price9.00
Prev Close6.83
Price6.80
Change %-0.44%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Sep 19, 2023ResumedCCraig HallumHold$9+32.4%
Aug 11, 2023DowngradeMMaxim GroupBuy → Hold
Mar 13, 2023UpgradeDDA DavidsonUnderperform → Neutral$12 → $15+120.6%
Aug 05, 2022UpgradeMMaxim GroupHold → Buy$36+429.4%
Aug 05, 2022UpgradeRB. Riley SecuritiesNeutral → Buy$31+355.9%
May 09, 2022DowngradeDDA DavidsonNeutral → Underperform$69 → $13+91.2%
May 06, 2022DowngradeCCraig HallumBuy → Hold$90 → $30+341.2%
Jun 03, 2021DowngradeMMaxim GroupBuy → Hold
Mar 05, 2021ReiteratedMMaxim GroupBuy$28 → $54+694.1%
Jun 25, 2020ResumedCCraig HallumBuy$24+252.9%

Peers

Mkt cap
TickerCompanyMkt cap
USPHU.S. Physical Therapy Inc1.49B
AIRSAirsculpt Technologies Inc59.55M
CONConcentra Group Holdings Parent Inc5.50B
PARKPark Dental Partners Inc104.95M
BTMDbiote Corp60.74M
WWWW International Inc130.49M
LFSTLifeStance Health Group Inc5.46B
HNGEHinge Health Inc9.49B
XPOFXponential Fitness Inc235.52M
PLNTPlanet Fitness Inc4.62B

Insider trading

11 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
JOBSON CHARLES E10% OwnerNov 06 '26Buy6.651791,1901,794,033Nov 10 06:00 PM
JOBSON CHARLES E10% OwnerMay 12 '26Buy8.57127,6761,094,1831,773,479May 14 06:00 PM
JOBSON CHARLES E10% OwnerApr 21 '26Buy8.585094,3671,645,803Apr 23 06:30 PM
JOBSON CHARLES E10% OwnerFeb 12 '26Buy8.5015,397130,8741,645,294Feb 17 05:36 PM
JOBSON CHARLES E10% OwnerFeb 11 '26Buy8.704483,8981,639,597Feb 13 05:16 PM
JOBSON CHARLES E10% OwnerJan 23 '26Buy10.0016,753167,5301,638,424Jan 27 08:45 PM
JOBSON CHARLES E10% OwnerJan 06 '26Buy8.895,24046,5841,621,671Jan 08 06:00 PM
JOBSON CHARLES E10% OwnerDec 31 '25Buy8.7011961,615,038Jan 05 05:30 PM
JOBSON CHARLES E10% OwnerDec 05 '25Buy8.4110,00084,1001,615,027Dec 09 04:45 PM
JOBSON CHARLES E10% OwnerDec 01 '25Buy8.4113,000109,3301,605,027Dec 03 06:24 PM
JOBSON CHARLES E10% OwnerNov 21 '25Buy8.5010,00085,0001,599,946Nov 25 05:23 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
SMLFiShares U.S. Small-Cap Equity Factor ETFAUM: 4.26B
DFMCU.S. Micro Cap Portfolio ETF Class SharesAUM: 212.10M
DFACU.S. Core Equity 2 Portfolio-ETF Class SharesAUM: 49.14B
IWCiShares Micro-Cap ETFAUM: 1.22B
DCORUS Core Equity 1 Portfolio ETF Class SharesAUM: 3.65B
AVSCAvantis U.S Small Cap Equity ETFAUM: 3.23B
AVUVAvantis U.S. Small Cap Value ETFAUM: 32.39B

News

latest 14 of 198
  • The Joint Corp. Misses And Cuts Its Top-Line Outlook, But The Asset-Light Profit Engine Keeps Improving (Earnings Whispers) -7.06%
  • The Joint Corp. Reports Third Quarter 2026 Financial Results (GlobeNewswire)
  • The Joint Needs Comps To Turn Positive To Make Its Pure-Play Franchisor Pitch Stick (Earnings Whispers)
  • The Joint Corp. to Report 2026 Third Quarter Results on Thursday, November 5 and Host Conference Call and Webcast (GlobeNewswire)
  • The Joint Chiropractic Expands Growth Opportunities Through Strategic Territory Reacquisition (PR Newswire)
  • The Joint Corp (JYNT) (Q2 2026) Earnings Call Highlights: Refranchising Nears Completion, ... (GuruFocus.com)
  • The Joint Corp. Reports Second Quarter 2026 Financial Results (GlobeNewswire)
  • Earnings To Watch: The Joint Corp (JYNT) Q2 2026 -- GF Value Sees 46% Upside (GuruFocus.com)
  • The Joint Chiropractic Earns Entrepreneur Recognition as a Premier Multi-Unit Franchise Investment (PR Newswire)
  • The Joint Corp. to Report 2026 Second Quarter Results on Thursday, August 6 and Host Conference Call and Webcast (GlobeNewswire)
  • The Joint Chiropractic Expands to 44th State with Opening of Rhode Island Clinic (PR Newswire)
  • The Joint Corp. Announces Milind Pant Elected as Director (GlobeNewswire)
  • The Joint Corp. Reports First Quarter 2026 Financial Results (GlobeNewswire)
  • The Joint Corp (JYNT) Q1 2026 Earnings Report Preview: What To Expect (GuruFocus.com)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-050.1000.080-0.01013.5514.853
2026Q22026-08-06-0.0100.0470.04615.1814.573
2026Q12026-05-070.0800.0330.09214.8214.503
2025Q42026-03-120.0600.0400.06815.1714.123
2025Q32025-11-060.0200.0200.05613.3813.334
2025Q22025-08-07-0.053-0.0430.00613.2713.323
2025Q12025-05-08-0.0300.0030.06413.0816.024
2024Q42025-03-13-0.1800.0100.00114.4528.995
2024Q32024-11-08-0.2100.008-0.21230.2028.385
2024Q22024-08-08-0.240-0.018-0.24130.2629.405
2024Q12024-05-020.0600.0050.06429.7229.594
2023Q42024-03-07-0.7500.012-0.74830.6129.085
2023Q32023-11-09-0.0500.018-0.04829.4729.065
2023Q22023-09-13-0.0100.013-0.02229.3129.894
2023Q12023-05-040.150-0.0060.15728.4527.915
2022Q42023-03-090.0400.0750.03727.8127.326

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2017FY-0.018-0.263-0.25925.1624.87
2018FY0.0200.0020.01031.7931.24
2019FY0.2300.2130.23048.4548.23
2020FY0.9000.3120.90358.6858.30
2021FY0.4800.5230.44081.1980.67
2022FY0.0800.1180.043101.91101.42
2023FY-0.6500.102-0.664117.7116.19
2024FY-0.560-0.374-0.38951.90119.19
2025FY-0.020-0.037-0.02054.9053.84
2026FY-0.244--58.12
2027FY-0.322--58.23
2028FY--0.010--55.87

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-1041314.7013.3515.97
2026Q4S2026-11-0941215.1714.5815.97
2026Q4S2026-11-0640315.0514.5815.49
2026Q4S2026-10-2140016.0515.2417.20
2026Q4S2026-08-0741216.0515.2417.20
2026Q4S2026-07-2240016.1014.7117.30
2026Q4S2026-05-2741116.1014.7117.30
2026Q4S2026-05-0842216.1014.7117.30
2026Q4S2026-03-1642116.1414.7117.64
2026Q4S2026-03-1342116.1414.7117.64
2026Q4S2026-01-2130015.8715.3516.40
2026Q4S2025-12-2231215.8715.3516.40
2026Q4S2025-11-1141216.1615.3517.00
2026Q4S2025-11-1041216.1615.3517.00

Estimate history

EPS, annual-0.2590.010.230.9030.440.043-0.664-0.3890.1920.197
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.2120.0010.0640.0060.0560.0680.0920.046-0.008
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual24.91936.66248.45158.68380.86101.25246.97752.16354.89658.72
Period201720182019202020212022202320242025TTM
Sales, quarterly30.19814.71413.07813.2713.38115.16714.8215.18213.552
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual13.58613.74313.88314.15714.4214.52814.75215.1614.14313.702
Period201720182019202020212022202320242025MRQ
Shares, quarterly14.95815.1615.31115.33115.17214.14314.26814.213.702
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue58.7254.9052.1646.98101.2580.8658.6848.4536.66
Cost of Goods Sold Incl. D&A11.9612.9412.8911.7615.8214.609.247.475.87
Gross Profit46.7641.9639.2835.2285.4366.2649.4440.9930.80
Selling, General and Administrative Excl. Other42.0441.7740.6234.1181.8460.3143.9637.4630.06
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income4.730.19-1.341.113.595.955.483.530.74
Interest Expense0.000.00-0.060.13---0.00
Unusual Expense1.921.090.480.812.360.570.04-0.020.29
Net Income Before Taxes3.28-0.23-1.610.250.705.285.413.370.11
Income Taxes0.030.040.0111.020.07-1.29-7.750.05-0.04
Consolidated Net Income3.24-0.27-1.61-10.770.636.5813.173.320.15
Net Income From Continuing Operations3.24-0.27-1.61-10.770.636.5813.173.320.15
Net Income2.832.91-5.80-9.750.636.5813.173.320.15
EPS (Recurring)0.300.24-0.37-0.630.150.470.900.230.01
EPS (Basic, Before Extraordinaries)0.200.19-0.39-0.660.040.460.940.240.01
EPS (Diluted)0.200.19-0.39-0.660.040.440.900.230.01
EBITDA6.261.900.032.3910.2412.048.225.432.29
Non-Operating Income (Expense)0.470.680.210.02-0.41-0.10-0.03-0.18-0.63
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense1.081.021.331.371.370.770.650.530.50
Price To Earnings Ratio34.6734.67-78.00245.26136.8529.2970.14504.24
Price To Sales Ratio1.772.403.043.002.0512.136.534.823.18
Gross Margin79.6476.4375.2974.9784.3881.9484.2584.5984.00
Operating Margin8.050.34-2.582.363.557.369.347.282.01
Net Margin4.815.30-11.11-20.760.628.1322.446.860.40
Shares Outstanding13.7014.1415.1614.7514.5314.4214.1613.8813.74
Market Capitalization93.5093.50159.28141.79203.13946.81368.72223.75114.20

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue13.5515.1814.8215.1713.3813.2713.0814.71
Cost of Goods Sold Incl. D&A2.672.903.133.263.113.193.363.54
Gross Profit10.8912.2811.6911.9010.2710.089.7211.18
Selling, General and Administrative Excl. Other9.2211.6710.1710.989.7610.7210.3310.30
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income1.670.611.530.930.52-0.65-0.610.87
Interest Expense0.000.000.000.000.000.000.00-
Unusual Expense0.340.770.630.180.360.490.070.00
Net Income Before Taxes1.47-0.241.110.940.30-0.98-0.490.89
Income Taxes0.010.010.010.000.010.010.01-0.02
Consolidated Net Income1.46-0.251.100.940.29-0.99-0.510.91
Net Income From Continuing Operations1.46-0.251.100.940.29-0.99-0.510.91
Net Income-0.120.651.300.990.860.090.970.02
EPS (Recurring)0.010.080.120.080.070.030.070.00
EPS (Basic, Before Extraordinaries)-0.010.050.090.070.060.010.060.00
EPS (Diluted)-0.010.050.090.070.060.010.060.00
EBITDA1.931.031.931.370.96-0.23-0.221.22
Non-Operating Income (Expense)0.14-0.080.210.200.140.160.180.02
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.270.330.220.260.270.260.230.16
Price To Earnings Ratio34.6739.7145.7868.93----
Price To Sales Ratio1.772.142.222.322.702.492.151.52
Gross Margin80.3380.8978.9078.4976.7775.9574.3075.95
Operating Margin12.334.0010.306.113.86-4.86-4.665.92
Net Margin-0.874.308.776.536.390.707.400.12
Shares Outstanding13.7014.2014.2714.1415.1715.3315.3115.16
Market Capitalization93.50125.16124.91129.63146.38176.59189.53159.28

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments24.3026.0019.2110.5519.9120.828.648.854.32
Short Term Receivables2.852.592.583.913.702.062.770.961.31
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets23.9944.9421.492.102.281.571.120.880.54
Total Current Assets51.1473.5243.2916.5625.8924.4512.5410.696.17
Net Property, Plant & Equipment4.733.764.2738.0632.8120.3319.073.663.80
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable------0.000.130.35
Intangible Assets--12.3719.4210.497.497.374.864.68
Deferred Tax Assets--1.0311.939.197.94---
Other Assets5.095.8739.657.527.075.674.734.093.43
Total Assets60.9783.1587.2193.4985.4565.8843.7123.4318.44
Short Term Debt Incl. Current Port. of LT Debt0.190.480.415.324.665.722.341.100.10
Accounts Payable1.591.751.252.971.711.561.531.251.07
Other Current Liabilities31.0346.8131.9114.9315.0711.189.707.924.21
Total Current Liabilities32.8249.0433.5723.2221.4418.4613.5710.275.38
Long Term Debt1.820.312.4520.7418.9612.7711.940.001.00
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities--0.06---0.090.080.14
Other Liabilities11.2513.1226.3616.9515.4913.5312.3912.3510.77
Total Liabilities45.8962.4862.4460.9055.8844.7537.9922.7017.28
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity15.0520.6524.7532.5629.5421.135.720.731.15
Total Shareholders Equity15.0520.6524.7532.5629.5421.135.720.731.15
Accumulated Minority Interest0.030.030.030.030.030.000.000.000.00
Total Equity15.0820.6824.7732.5929.5721.135.720.731.15
Total Liabilities & Stockholders Equity60.9783.1587.2193.4985.4565.8843.7123.4318.44
Book Value Per Share1.061.361.682.242.051.490.410.050.08
Tangible Book Value Per Share1.061.361.680.901.320.96-0.12-0.30-0.26
Full-Time Employees330736794781601225150138148
Price to Book Ratio7.647.784.026.4532.0617.9239.1748.4214.25
Return on Assets-0.37-1.90-11.920.708.7024.039.890.70-19.34
Return on Equity-1.50-7.11-37.582.0226.1598.0982.2515.60-84.97
Return on Invested Capital17.23-27.65-35.861.1813.5638.8518.8320.16-159.39
Quick Ratio1.561.501.290.711.211.320.921.041.15
Current Ratio1.561.501.290.711.211.320.921.041.15

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income2.416.08-10.06-9.750.636.5813.173.320.15
Depreciation1.531.714.728.586.656.092.731.901.56
Other Funds (Non Cash)6.953.5113.704.151.621.050.830.700.98
Funds from Operations10.9911.408.3113.888.4512.478.635.932.61
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-7.50-9.561.100.80-0.242.772.551.602.84
Cash from Operating Activities3.491.849.4214.688.2115.2311.187.525.45
Capital Expenditures-1.22-1.50-1.19-5.00-5.90-8.38-4.20-4.17-1.39
Net Assets From Acquisitions0.000.000.00-1.19-12.11-5.77-0.53-3.12-0.10
Sale of Fixed Assets and Businesses1.437.780.550.000.110.000.00--
Purchase or Sale of Investments0.000.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.130.150.25
Cash from Investing Activities0.216.27-0.63-6.19-17.90-14.14-4.60-7.14-1.24
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-14.65-9.800.020.200.380.810.980.520.33
Repurchase of Common Pref Stock-14.75-11.32-0.01-0.00-0.01-0.71-0.03-0.02-0.00
Sale of Common Pref Stock0.101.520.030.200.381.521.010.550.33
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.00-0.00-2.03-0.02-0.05-2.814.62-1.120.00
Change in Long Term Debt0.00-0.00-2.03-0.02-0.05-2.814.62-1.120.00
Issuance of Long Term Debt0.000.000.000.000.000.004.680.000.00
Reduction of Long Term Debt0.00-0.00-2.03-0.02-0.05-2.81-0.06-1.120.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities-14.65-9.81-2.000.170.33-2.005.60-0.600.33
Net Change in Cash-10.95-1.696.788.66-9.36-0.9112.18-0.214.53
Free Cash Flow2.260.338.239.682.318.248.034.044.34
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow45.85394.2919.2714.5889.96119.0247.7157.8226.89
Deferred Taxes & Investment Tax Credit-0.09-0.0610.90-0.44-1.25-8.100.00-0.08

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments18.8723.0021.4324.3030.7131.00
Short Term Receivables2.592.412.342.852.902.79
Inventories0.000.000.000.000.000.00
Other Current Assets10.5417.5024.9223.9925.7829.00
Total Current Assets31.9942.9148.6951.1459.3962.79
Net Property, Plant & Equipment4.204.284.564.734.674.86
Total Investments and Advances0.000.000.000.000.000.00
Other Assets4.194.444.685.095.335.54
Total Assets40.7051.6357.9260.9769.3973.18
Short Term Debt Incl. Current Port. of LT Debt0.350.340.280.190.190.19
Accounts Payable0.751.100.961.591.201.58
Other Current Liabilities15.6522.5428.9331.0331.6533.74
Total Current Liabilities16.7523.9830.1732.8233.0535.51
Long Term Debt1.611.701.761.821.901.98
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities10.0810.0810.4911.2511.7212.43
Total Liabilities28.4335.7542.4345.8946.6649.92
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity12.2415.8515.4715.0522.7023.24
Total Shareholders Equity12.2415.8515.4715.0522.7023.24
Accumulated Minority Interest0.030.030.030.030.030.03
Total Equity12.2715.8815.4915.0822.7223.26
Total Liabilities & Stockholders Equity40.7051.6357.9260.9769.3973.18
Book Value Per Share0.891.121.081.061.501.52
Tangible Book Value Per Share0.891.121.081.061.501.52
Full-Time Employees---330--
Price to Book Ratio7.648.108.315.836.298.87
Return on Assets5.903.331.94-0.37-0.40-4.82
Return on Equity18.5710.647.00-1.50-1.37-16.16
Return on Invested Capital-0.853.727.545.873.480.37
Quick Ratio1.911.791.611.561.801.77
Current Ratio1.911.791.611.561.801.77

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-1.691.561.501.051.421.18
Depreciation0.260.420.400.440.460.42
Other Funds (Non Cash)4.180.490.272.020.710.93
Funds from Operations2.752.472.173.602.592.53
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-2.88-0.28-3.64-0.70-0.82-1.66
Cash from Operating Activities-0.132.19-1.482.901.770.87
Capital Expenditures-0.38-0.26-0.23-0.35-0.32-0.51
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.271.160.000.000.007.74
Purchase or Sale of Investments0.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities-0.110.90-0.23-0.35-0.327.23
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-3.83-0.70-1.16-8.96-1.740.00
Repurchase of Common Pref Stock-3.83-0.70-1.20-9.02-2.290.00
Sale of Common Pref Stock0.000.000.040.070.550.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-3.83-0.70-1.16-8.96-1.740.00
Net Change in Cash-4.072.40-2.88-6.41-0.298.10
Free Cash Flow-0.511.94-1.712.551.460.36
Price to Free Cash Flow45.8529.5847.26379.8889.9952.56

Revenue breakdown

Advertising2024: 9.18M 2025: 10.45M
Franchise2024: 3.00M 2025: 3.37M
Product and Service, Other2024: 2.15M 2025: 1.83M
Royalty2024: 32.14M 2025: 33.20M
Technology Service2024: 5.69M 2025: 6.04M
United States2024: 52.16M 2025: 54.90M
Consolidation, Policy2024: 266.83K
Franchise Operations2024: 51.90M
Total Patent Owners & Lessors revenue2025: 54.90M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-302.73%0.3M11.9M76.52K
2026-10-152.95%0.3M11.9M78.76K
2026-09-303.42%0.4M11.9M81.85K
2026-09-153.71%0.4M11.9M104.64K
2026-08-313.37%0.4M11.9M106.55K
2026-08-143.55%0.4M11.9M111.03K
2026-07-313.86%0.5M12.0M110.15K
2026-07-153.95%0.5M12.0M107.80K
2026-06-303.94%0.5M12.0M94.64K
2026-06-155.65%0.7M12.0M73.61K
2026-05-296.27%0.8M12.0M70.09K
2026-05-156.62%0.8M12.0M64.81K
2026-04-306.73%0.8M12.2M60.59K
2026-04-157.64%0.9M12.2M64.21K
2026-03-317.34%0.9M12.1M68.74K
2026-03-138.20%1.0M12.1M63.68K
2026-02-277.76%1.0M12.7M69.27K
2026-02-137.42%0.9M12.7M86.06K
2026-01-308.41%1.1M12.7M98.57K
2026-01-157.50%1.0M12.7M101.20K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.503.305.300.0010.9420.000.000.925-0.0930.001
call5.000.902.750.004.7810.000.000.784-0.0870.003
call7.500.001.550.004.3130.000.000.576-0.1010.004
call10.000.001.500.005.6390.000.000.500-0.1350.004
call12.500.001.500.006.5820.000.000.468-0.1570.004
call15.000.001.500.007.2820.000.000.448-0.1730.004
put2.500.001.000.0010.9580.000.00-0.075-0.0930.001
put5.000.001.000.004.9580.000.00-0.216-0.0870.003
put7.500.001.650.732.89922.000.00-0.424-0.1010.004
put10.002.254.200.004.4700.000.00-0.500-0.1340.004
put12.504.706.700.005.4040.000.00-0.532-0.1560.004
put15.007.209.200.006.0960.000.00-0.552-0.1710.004

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-104Statement of changes in beneficial ownership of securities2026-11-06SEC
2026-11-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-03SEC
2026-10-018-KCurrent report2026-10-01SEC
2026-08-0710-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-07-28SCHEDULE 13G/ASEC
2026-06-124Statement of changes in beneficial ownership of securities2026-06-10SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-06-033Initial statement of beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-224Statement of changes in beneficial ownership of securities2026-05-20SEC
2026-05-218-KCurrent report2026-05-20SEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-144Statement of changes in beneficial ownership of securities2026-05-12SEC
2026-05-0810-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-078-KCurrent report2026-05-01SEC
2026-05-018-KCurrent report2026-04-27SEC
2026-04-248-KCurrent report2026-04-20SEC
2026-04-23SCHEDULE 13G/ASEC
2026-04-234Statement of changes in beneficial ownership of securities2026-04-21SEC
2026-04-07DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-07DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-04-07SEC
2026-03-27SCHEDULE 13G/ASEC
2026-03-16SCHEDULE 13D/ASEC
2026-03-1310-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-128-KCurrent report2026-03-12SEC
2026-03-114Statement of changes in beneficial ownership of securities2026-03-09SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-111.19K100
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-051.09M100
2026-044.37K100
2026-030000
2026-02134.77K200
2026-01214.11K200
2025-12193.53K300
2025-1185.00K100

Institutional holders

Manager% owned
Bandera Partners LLC27.62%
Skylands Capital, LLC6.69%
JCP Investment Management, LLC4.17%
VANGUARD CAPITAL MANAGEMENT LLC3.91%
FIRST FOUNDATION ADVISORS2.35%
BlackRock, Inc.2.02%
JANE STREET GROUP, LLC1.65%
VANGUARD PORTFOLIO MANAGEMENT LLC1.58%
RENAISSANCE TECHNOLOGIES LLC1.54%
DIMENSIONAL FUND ADVISORS LP1.11%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.74%
Fundamental Family Office Allocation Fund2.14%
VANGUARD EXTENDED MARKET INDEX FUND1.10%
Fidelity Small Cap Index Fund0.78%
VANGUARD EXPLORER FUND0.57%
VANGUARD STRATEGIC EQUITY FUND0.47%
Fidelity Extended Market Index Fund0.46%
U.S. Small Cap Equity Fund0.46%
Goldman Sachs Absolute Return Tracker Fund0.39%
SMALL COMPANY GROWTH PORTFOLIO0.38%

OakChart. JYNT. Cached 15 minutes.